Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This entry refers to a clinical trial comparison between **orlistat** and **metformin** conducted by the Sheffield Teaching Hospitals NHS Foundation Trust. Orlistat is a gastrointestinal lipase inhibitor used for weight management by preventing the absorption of dietary fats. Metformin is a biguanide antihyperglycemic agent that improves insulin sensitivity and is frequently used off-label to treat polycystic ovary syndrome (PCOS) and related anovulation. The study specifically investigates the efficacy of these two agents in inducing weight loss and restoring ovulation in obese women who are experiencing anovulatory infertility. While both drugs are well-established in their respective primary indications, this trial (NCT00406133) aimed to determine the optimum management strategy for reproductive dysfunction in the context of obesity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on orlistat + metformin.